// App-Quantinova.ai

: Relationship between baseline rescue medication use and reductions in COPD exacerbation rates: a subgroup analysis of the ETHOS trial

Researchers

Presenter

  • John R Hurst

Principal Investigators

  • Meilan Han

  • Bartolome R Celli

  • Mona Bafadhel

  • Martin Jenkins

  • Paul Dorinsky

  • Mehul Patel

Medical Centers

  • UCL Respiratory, University College London, London, United Kingdom

  • Astra Zeneca, Cambridge, United Kingdom

  • Division of Pulmonary and Critical Care Medicine, University of Michigan, Ann Arbor, United States of America

  • Division of Pulmonary and Critical Care Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, United States of America

  • Respiratory Medicine Unit, Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom,

Locations

  • United States

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Pulmonary/Respiratory Diseases

Disease

  • Chronic obstructive pulmonary disease

Biomarkers

  • Catalase

Drug/Treatment

  • Seebri Breezhaler

  • Budesonide

  • Formoterol

Outcome

  • N/A

Study Design

  • Randomized

Phase

  • N/A

Study Id's

  • NCT02465567

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved